Is a complete AGIO research report available?

No complete published report is available for Agios Pharmaceuticals, Inc. (AGIO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Agios Pharmaceuticals, Inc. (AGIO)

NASDAQ: AGIO · USD

$35.0

-0.98 (-2.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AGIO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.1B
Revenue (ttm)	66M
Net income (ttm)	-422.6M
EPS (ttm)	-$7.25
Shares out	59.5M
Volume	1,155,275
Beta	0.54
Price target	$42.8	+22.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 66M
Net income (ttm): -422.6M
EPS (ttm): -$7.25
Market cap: 2.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All AGIO indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001439222
Company name	Agios Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	00847X104
Employees	540
Employees Change	52%
Employees Change Percent	10.66
Enterprise value	$1.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2013-07-24
Isin	US00847X1046
Last refreshed	2026-07-30
Market cap	$2.1B
Market cap category	Mid-Cap
Price	$35.01
Price currency	USD
Rev Per Employee	122,311.11x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	AGIO
Website	https://www.agios.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-20.3%
EV Sales Forward	7.82x
EV/Sales	16.24x
FCF yield	-18.48%
P/B ratio	1.87x
P/S ratio	31.52x
PS Forward	15.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-719.97%
EBITDA Margin	-712.01%
Gross Profit	$-288.5M
Net Income	$-422.6M
Net Income Growth Years	0%
Pretax Margin	-641.38%
Profit Per Employee	$-782,598
ROA	-21.69
Roa5y	-20.34
ROCE	-42.23
ROE	-32.82
Roe5y	-14.25
ROIC	-120.9
Roic5y	-138.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.23%
Cagr1y	-5.89%
Cagr3y	9.62%
Cagr5y	-6.88%
EPS Growth Years	0
Revenue Growth	78.34x
Revenue Growth Q	137.75x
Revenue Growth Quarters	13x
Revenue Growth Years	3x
Revenue Growth3 Y	51.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$1.2B
Cash	$737M
Current Assets	$834.8M
Current Liabilities	$58.8M
Debt	$35.7M
Debt Equity	$0.03
Equity	$1.1B
Liabilities	$75.9M
Long Term Assets	$350.1M
Long Term Liabilities	$17M
Net Cash	$1B
Net Cash By Market Cap	$48.5
Net Cash Growth	-26.39%
Net Debt Equity	$-0.91
Tangible Book Value	$1.1B
Tangible Book Value Per Share	$18.69
WACC	7.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.19
Inventory Turnover	10.96
Net Working Capital	$57.8M
Quick ratio	12.8
Working Capital	$776M
Working Capital Turnover	$0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.25%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-20.18%
1Y total return	-5.89%
200-day SMA	31.72
3Y total return	31.72%
50-day SMA	34.06
50-day SMA vs 200-day SMA	50over200
5Y total return	-29.98%
All Time High	138.9
All Time High Change	-74.79%
All Time High Date	2015-01-15
All Time Low	15.77
All Time Low Change	122%
All Time Low Date	2013-11-18
ATR	1.83
Beta	0.54
Beta1y	2.3
Beta2y	1.89
Ch YTD	28.62
High	36.37
High52	46
High52 Date	2025-11-18
High52ch	-23.89%
Low	34.87
Low52	22.24
Low52 Date	2025-11-19
Low52ch	57.42%
Ma50ch	2.8%
Premarket Change Percent	1.11
Premarket Price	$36.39
Price vs 200-day SMA	10.37%
RSI	42.5
RSI Monthly	51.33
RSI Weekly	54.47
Sharpe ratio	0.35x
Sortino ratio	0.49
Total Return	-0.25%
Tr YTD	28.62
Tr1m	-7.63%
Tr1w	-2.88%
Tr3m	41.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	6
Analyst Price Target Top	$36.33
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-1.71
Earnings Revenue Estimate	25,638,264x
Earnings Revenue Estimate Growth	105.85x
Operating Income	$-475.5M
Operating margin	-720
Price target	$42.75
Price Target Change	$22.11
Price Target Change Top	$3.77

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,061,598%
Float Percent	84.18%
Shares Insiders	1.16%
Shares Institutions	92.31%
Shares Out	59,471,609
Shares Qo Q	0.74%
Shares Yo Y	0.25%
Short Float	13.24%
Short Ratio	5.44
Short Shares	11.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-441.5M
Adjusted OCF	-437,142,000
Average Volume	1,073,442.85x
Bv Per Share	18.69
CAPEX	$-4.3M
Ch10y	-20.18
Ch1m	-7.63
Ch1w	-2.88
Ch1y	-5.89
Ch3m	41.17
Ch3y	31.72
Ch5y	-29.98
Ch6m	23.67
Change	-2.72%
Change From Open	-2.29
Close	35.99
Days Gap	-0.44
Depreciation Amortization	5,262,000
Dollar Volume	40,446,177.8
Earnings Date	2026-07-30
Earnings Time	bmo
EBIT	$-475.5M
EBITDA	$-470.3M
EPS	$-7.25
F Score	3
FCF	$-384.7M
FCF EV Yield	-35.88x
FCF Per Share	$-6.47
Financing CF	9,135,000
Fiscal Year End	December
Founded	2,007
Income Tax	$-1M
Investing CF	405,909,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-12
Ma150	30.5
Ma150ch	14.81%
Ma20	38.78
Ma20ch	-9.72%
Net CF	34,636,000
Next Earnings Date	2026-10-29
Open	35.83
Optionable	Yes
Position In Range	9.33
Post Close	35.01
Postmarket Change Percent	1.4
Postmarket Price	$35.5
Ppne	37,762,000
Pre Close	35.99
Price Date	2026-07-29
Ptbv Ratio	1.88
Relative Volume	1.08x
Revenue	66,048,000x
SBC By Revenue	85.9x
Share Based Comp	56,734,000
Tax By Revenue	-1.54x
Tr6m	23.67%
Us State	Massachusetts
Volume	1,155,275
Z Score	13.86

Agios Pharmaceuticals, Inc. (AGIO)

Coverage state: Market snapshot only — no published research

Generate the first AGIO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · AGIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AGIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AGIO

Frequently asked questions